| Literature DB >> 30055079 |
Christopher Cunniff1, Amir Reza Djavid1, Steven Carrubba1, Bernard Cohen2, Nathan A Ellis3, Carolyn Fein Levy4, Stacy Jeong1, Howard M Lederman2, Maria Vogiatzi5, Michael F Walsh6, Ann Graham Zauber7.
Abstract
Bloom Syndrome (BSyn) is an autosomal recessive disorder that causes growth deficiency, endocrine abnormalities, photosensitive skin rash, immune abnormalities, and predisposition to early-onset cancer. The available treatments for BSyn are symptomatic, and early identification of complications has the potential to improve outcomes. To accomplish this, standardized recommendations for health supervision are needed for early diagnosis and treatment. The purpose of this report is to use information from the BSyn Registry, published literature, and expertise from clinicians and researchers with experience in BSyn to develop recommendations for diagnosis, screening, and treatment of the clinical manifestations in people with BSyn. These health supervision recommendations can be incorporated into the routine clinical care of people with BSyn and can be revised as more knowledge is gained regarding their clinical utility.Entities:
Keywords: Bloom syndrome; DNA repair; cancer surveillance; chromosome instability; health supervision
Mesh:
Year: 2018 PMID: 30055079 DOI: 10.1002/ajmg.a.40374
Source DB: PubMed Journal: Am J Med Genet A ISSN: 1552-4825 Impact factor: 2.802